HMGA1 As a Potential Prognostic and Therapeutic Biomarker in Breast Cancer

Table 1

The clinicopathological parameters of cases used in IHC.

	No.
Age
(i) ≥ 50	22
(ii) <50	17
Tumor subtype
(i) Normal breast-like	4
(ii) Luminal A	10
(iii) Luminal B	14
(iv) HER2	7
(v) Basal-like	4
Lymph node invasion
Negative	20
(i) Positive	19
Histological grade
(ii) I	14
(iii) II	13
(iv) III	12